Selinexor 60 MG
Pro2020-0369
Phase 2 small_molecule on_hold
Quick answer
Selinexor 60 MG for Multiple Myeloma is a Phase 2 program (small_molecule) at Karyopharm Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Karyopharm Therapeutics
- Indication
- Multiple Myeloma
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- on_hold